Eden Research PLC, an AIM-quoted company focused on sustainable biopesticides and plastic-free formulation technology, has released its Annual Report and Accounts for the year ended 31 December 2023. The Notice of the Annual General Meeting (AGM) has been issued to shareholders and is available on the company's website. The AGM is scheduled for Thursday 27 June 2024 at 11.00am in London.

Eden Research is the only UK-listed company concentrating on biopesticides for sustainable agriculture. It develops and supplies innovative biopesticide products and natural microencapsulation technologies to the global crop protection, animal health, and consumer products industries. The company's products are formulated with terpene active ingredients, based on natural plant defense metabolites. Eden has three products currently on the market.

Mevalone® is a foliar biofungicide targeting a key disease affecting grapes and other high-value fruit and vegetable crops. Cedroz™ is a bionematicide that targets free-living nematodes affecting various high-value fruit and vegetable crops globally. Ecovelex, a seed treatment product, was developed to tackle crop destruction caused by birds. Additionally, Eden's Sustaine® encapsulation technology is used to harness the biocidal efficacy of naturally occurring chemicals produced by plants and can be used with both natural and synthetic compounds to enhance their performance and ease-of-use.

Eden Research was admitted to trading on AIM in 2012 and was awarded the London Stock Exchange Green Economy Mark in 2021, recognizing companies that derive over 50% of their total annual revenue from products and services contributing to the global green economy. Eden derives 100% of its total annual revenues from sustainable products and services.